CLS (CLI) Share Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CLS in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CLI shares.
View CLI analyst ratings or view top-rated stocks.

2 brokerages have issued 12-month price targets for CLS's stock. Their CLI share price forecasts range from GBX 175 to GBX 190. On average, they expect the company's stock price to reach GBX 182.50 in the next twelve months. This suggests a possible upside of 47.2% from the stock's current price.
View analysts price targets for CLI or view top-rated stocks among Wall Street analysts.

CLS's stock was trading at GBX 158.80 at the start of the year. Since then, CLI shares have decreased by 21.9% and is now trading at GBX 124.
View the best growth stocks for 2023 here.

CLS Holdings plc (LON:CLI) released its earnings results on Wednesday, August, 12th. The company reported $5.30 EPS for the quarter. CLS had a negative trailing twelve-month return on equity of 16.88% and a negative net margin of 142.17%.

CLS announced a dividend on Wednesday, August 9th. Stockholders of record on Thursday, September 7th will be given a dividend of GBX 2.60 per share on Tuesday, October 3rd. This represents a yield of 1.81%. The ex-dividend date is Thursday, September 7th. The official announcement can be viewed at this link.
Read our dividend analysis for CLI.

CLS (LON:CLI) pays an annual dividend of GBX 8 per share and currently has a dividend yield of 6.28%. CLI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CLI.

Based on aggregate information from My MarketBeat watchlists, some companies that other CLS investors own include Bank of Hawaii (BOH), InterDigital (IDCC), Derwent London (DLN), Oracle (ORCL), Petrofac (PFC), STAG Industrial (STAG), IP Group (IPO), London Stock Exchange Group plc (LSE.L) (LSE) and Agios Pharmaceuticals (AGIO).

CLS trades on the London Stock Exchange (LON) under the ticker symbol "CLI."

Shares of CLI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of CLI stock can currently be purchased for approximately GBX 124.

CLS (LON:CLI) has a market capitalization of £492.79 million and generates £143.70 million in revenue each year. The company earns £-204,300,000.00 in net income (profit) each year or GBX (0.51) on an earnings per share basis.

The company employs 109 workers across the globe.

CLS's mailing address is 86 Bondway, LONDON, SW8 1SF, United Kingdom. The official website for the company is www.clsholdings.com. The company can be reached via phone at +44-20-75827766.